Literature DB >> 7592337

Purification and characterization of the Pseudomonas aeruginosa NfxB protein, the negative regulator of the nfxB gene.

T Shiba1, K Ishiguro, N Takemoto, H Koibuchi, K Sugimoto.   

Abstract

The protein NfxB, involved in conferring resistance to quinolones in Pseudomonas aeruginosa, has a helix-turn-helix motif which is similar to that of other DNA-binding proteins. It appears to affect the membrane-associated energy-driven efflux of some antibiotics (H. Nikaido, Science 264:382-388, 1994). We constructed a plasmid that overproduced NfxB in Escherichia coli and purified the protein. Two species of NfxB (23 and 21 kDa), which are probably translated from different initiation codons, were isolated. Both proteins are also expressed in vivo in P. aeruginosa, with the 23-kDa NfxB being the major species. NfxB specifically binds upstream of the nfxB coding region as demonstrated by gel retardation and DNase I footprinting. Expression of the phi (nfxB'-lacZ+) (Hyb) gene was repressed in the presence of the nfxB gene product provided by a second compatible plasmid in E. coli. In the P. aeruginosa wild-type strain (PAO2142), NfxB was undetectable by immunoblotting; however, it was detected in the nfxB missense mutant (PK1013E). These results suggested that NfxB negatively autoregulates the expression of nfxB itself. Since the 54-kDa outer membrane protein (OprJ) (N. Masuda, E. Sakagawa, and S. Ohya, Antimicrob. Agents Chemother. 39:645-649, 1995) was overproduced in nfxB mutants, NfxB may also regulate the expression of membrane proteins that are involved in the drug efflux machinery of P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7592337      PMCID: PMC177412          DOI: 10.1128/jb.177.20.5872-5877.1995

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  21 in total

1.  Chromosomal location of genes participating in the degradation of purines in Pseudomonas aeruginosa.

Authors:  H Matsumoto; S Ohta; R Kobayashi; Y Terawaki
Journal:  Mol Gen Genet       Date:  1978-11-29

2.  Use of T7 RNA polymerase to direct expression of cloned genes.

Authors:  F W Studier; A H Rosenberg; J J Dunn; J W Dubendorff
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

3.  Sequence and transcriptional start site of the Pseudomonas aeruginosa outer membrane porin protein F gene.

Authors:  M Duchêne; A Schweizer; F Lottspeich; G Krauss; M Marget; K Vogel; B U von Specht; H Domdey
Journal:  J Bacteriol       Date:  1988-01       Impact factor: 3.490

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  In vitro gene fusions that join an enzymatically active beta-galactosidase segment to amino-terminal fragments of exogenous proteins: Escherichia coli plasmid vectors for the detection and cloning of translational initiation signals.

Authors:  M J Casadaban; J Chou; S N Cohen
Journal:  J Bacteriol       Date:  1980-08       Impact factor: 3.490

6.  Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa.

Authors:  K Hirai; S Suzue; T Irikura; S Iyobe; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

7.  Interactions between DNA-bound repressors govern regulation by the lambda phage repressor.

Authors:  A D Johnson; B J Meyer; M Ptashne
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

8.  A bacteriophage T7 RNA polymerase/promoter system for controlled exclusive expression of specific genes.

Authors:  S Tabor; C C Richardson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

9.  Outer membrane proteins responsible for multiple drug resistance in Pseudomonas aeruginosa.

Authors:  N Masuda; E Sakagawa; S Ohya
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

10.  RecA protein-dependent cleavage of UmuD protein and SOS mutagenesis.

Authors:  H Shinagawa; H Iwasaki; T Kato; A Nakata
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

View more
  22 in total

1.  Characterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeruginosa.

Authors:  T Köhler; S F Epp; L K Curty; J C Pechère
Journal:  J Bacteriol       Date:  1999-10       Impact factor: 3.490

2.  Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms.

Authors:  T R De Kievit; M D Parkins; R J Gillis; R Srikumar; H Ceri; K Poole; B H Iglewski; D G Storey
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 3.  Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria.

Authors:  Laura J V Piddock
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

Review 4.  Modes and modulations of antibiotic resistance gene expression.

Authors:  Florence Depardieu; Isabelle Podglajen; Roland Leclercq; Ekkehard Collatz; Patrice Courvalin
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

5.  NBTI 5463 is a novel bacterial type II topoisomerase inhibitor with activity against gram-negative bacteria and in vivo efficacy.

Authors:  Thomas J Dougherty; Asha Nayar; Joseph V Newman; Sussie Hopkins; Gregory G Stone; Michele Johnstone; Adam B Shapiro; Mark Cronin; Folkert Reck; David E Ehmann
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

6.  Mutator effects in Escherichia coli caused by the expression of specific foreign genes.

Authors:  Vanessa Gabrovsky; Mitsuko Lynn Yamamoto; Jeffrey H Miller
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

7.  The effects of active efflux pumps on antibiotic resistance in Pseudomonas aeruginosa.

Authors:  Huseyin Agah Terzi; Canan Kulah; Ihsan Hakkı Ciftci
Journal:  World J Microbiol Biotechnol       Date:  2014-06-26       Impact factor: 3.312

8.  Potent LpxC Inhibitors with In Vitro Activity against Multidrug-Resistant Pseudomonas aeruginosa.

Authors:  Kevin M Krause; Cat M Haglund; Christy Hebner; Alisa W Serio; Grace Lee; Vincent Nieto; Frederick Cohen; Timothy R Kane; Timothy D Machajewski; Darrin Hildebrandt; Chris Pillar; Mary Thwaites; Danielle Hall; Lynn Miesel; Meredith Hackel; Amanda Burek; Logan D Andrews; Eliana Armstrong; Lee Swem; Adrian Jubb; Ryan T Cirz
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

9.  Characterization of the MexC-MexD-OprJ multidrug efflux system in DeltamexA-mexB-oprM mutants of Pseudomonas aeruginosa.

Authors:  N Gotoh; H Tsujimoto; M Tsuda; K Okamoto; A Nomura; T Wada; M Nakahashi; T Nishino
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

Review 10.  Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.

Authors:  Philip D Lister; Daniel J Wolter; Nancy D Hanson
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.